Prescription drug · NDA
Gliadel (carmustine) NDC 24338-050
Carmustine 7.7 mg/1 · Wafer · Intracavitary · Azurity Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24338-050-08 | 24338005008 | 8 POUCH in 1 BOX (24338-050-08) / 1 WAFER in 1 POUCHMarketed from Dec 13, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gliadel
- Generic name (nonproprietary)
- carmustine
- Active ingredients
- Carmustine — 7.7 mg/1
- Dosage form
- Wafer
- Route
- Intracavitary
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020637
- Marketing start
- Listing expires
- Other FDA classes
- Alkylating Activity (Mechanism)
- Identifiers
- Product ID 24338-050_288ecd1b-0244-dd13-e063-6394a90a739dSPL ID 288ecd1b-0244-dd13-e063-6394a90a739dSPL set ID 38962a55-a514-4c48-bea5-f99a8da4beecRxCUI 212994, 309013UNII U68WG3173Y
- Pharmacologic class
- Alkylating Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N424338005008followed by a unit qualifier and the quantityPackage 24338-0050-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
GLIADEL Wafer is indicated for the treatment of patients with: newly-diagnosed high-grade glioma as an adjunct to surgery and radiation, and recurrent glioblastoma as an adjunct to surgery. GLIADEL Wafer is an alkylating drug indicated for the treatment of: newly-diagnosed high-grade glioma as an adjunct to surgery and radiation ( 1 ) and recurrent glioblastoma as an adjunct to surgery ( 1 )
Excerpt only. Read the full label for complete information.